Significant advances have been made in the treatment of both hepatitis B and C. Cure for the majority is becoming reality. Combination regimens are now established therapy in hepatitis C and the near future will see the adoption of a similar approach to hepatitis B. Interferon alpha therapy remains important, with the development of more efficacious pegylated forms. In this article we review current therapy and discuss future strategies of the therapy for chronic viral hepatitis.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1177/095632020101200401 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!